Economic burden of cardiorespiratory hospitalizations associated with respiratory syncytial virus among United States adults in 2017–2019

Economic burden of cardiorespiratory hospitalizations associated with respiratory syncytial virus among United States adults in 2017–2019

Morbidity and mortality caused by respiratory syncytial virus (RSV) in older adults and those with underlying health conditions can be potentially alleviated through vaccination. To assist vaccine policy decision-makers and payers, we estimated the annual economic burden of RSV-associated cardioresp...

Full description

Saved in:
Bibliographic Details
Main Authors: Deesha A Patel, Zachary A Marcum, Aisara Chansakul, Astra Toyip, Katherine Nerney, Catherine A Panozzo, Samantha St Laurent, Darshan Mehta, Parinaz Ghaswalla
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
RSV
respiratory
cardiorespiratory hospitalizations
economic burden
excess risk modeling
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2364493
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/21645515.2024.2364493

Similar Items